We are live on ! Find out more
LLY icon

Eli Lilly

1,176 hedge funds and large institutions have $66.5B invested in Eli Lilly in 2016 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 431 increasing their positions, 439 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more call options, than puts

Call options by funds: $1.37B | Put options by funds: $857M

16% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 58

1% more capital invested

Capital invested by funds: $66B → $66.5B (+$526M)

0% more funds holding in top 10

Funds holding in top 10: 3636 (0)

0.21% less ownership

Funds ownership: 75.93%75.72% (-0.21%)

0% less funds holding

Funds holding: 1,1791,176 (-3)

2% less repeat investments, than reductions

Existing positions increased: 431 | Existing positions reduced: 439

Holders
1,176
Holders Change
-3
Holders Change %
-0.25%
% of All Funds
31.38%
Holding in Top 10
36
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.96%
New
67
Increased
431
Reduced
439
Closed
58
Calls
$1.37B
Puts
$857M
Net Calls
+$514M
Net Calls Change
+$339M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
26
UBS AM
Illinois
$418M -$13.8M -172,153 -3%
PI
27
Putnam Investments
Massachusetts
$394M +$10.7M +133,534 +3%
BA
28
BlackRock Advisors
Delaware
$388M +$9.93M +124,090 +3%
Legal & General Group
29
Legal & General Group
United Kingdom
$380M +$2.69M +33,625 +0.7%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$375M +$55.8M +696,946 +18%
LCOV
31
London Company of Virginia
Virginia
$322M +$19.8M +247,475 +7%
APG Asset Management
32
APG Asset Management
Netherlands
$320M -$43M -537,500 -12%
Wells Fargo
33
Wells Fargo
California
$302M +$159M +1,983,356 +111%
Lazard Asset Management
34
Lazard Asset Management
New York
$259M -$50.3M -628,473 -16%
Swiss National Bank
35
Swiss National Bank
Switzerland
$257M -$3.64M -45,500 -1%
Morgan Stanley
36
Morgan Stanley
New York
$244M +$19.1M +238,661 +9%
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$243M -$2.45M -30,649 -1%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$239M -$117M -1,467,112 -33%
Charles Schwab
39
Charles Schwab
California
$233M +$1.57M +19,660 +0.7%
Sumitomo Mitsui Trust Group
40
Sumitomo Mitsui Trust Group
Japan
$232M +$2.63M +32,919 +1%
CCM
41
Causeway Capital Management
California
$209M +$6.44M +80,488 +4%
BlackRock
42
BlackRock
New York
$208M -$41.5M -518,489 -17%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$205M -$103M -1,282,609 -33%
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
$204M +$187M +2,330,615 +1,107%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$199M -$7.42M -92,700 -4%
Deutsche Bank
46
Deutsche Bank
Germany
$198M -$71.1M -888,379 -27%
BIM
47
BlackRock Investment Management
Delaware
$192M +$1.71M +21,414 +0.9%
Mitsubishi UFJ Trust & Banking
48
Mitsubishi UFJ Trust & Banking
Japan
$191M +$4.31M +53,865 +2%
US Bancorp
49
US Bancorp
Minnesota
$190M -$2.41M -30,155 -1%
Adage Capital Partners
50
Adage Capital Partners
Massachusetts
$187M +$53.9M +673,790 +41%

LLY Hedge Fund Activity: Q3 2016 in Review

1,176 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2016, worth a combined $66.5B — up 0.8% from $66B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new LLY positions and 58 closed out — a net gain of 9 holders — while 431 added to existing stakes and 439 trimmed.

The largest buyer was Balyasny Asset Management, adding an estimated $187M. The largest seller was Viking Global Investors, cutting an estimated $263M.

  • 1,176 institutional investors held Eli Lilly (LLY) as of Q3 2016, down from 1,179 in Q2 2016.
  • Funds reported $66.5B of Eli Lilly stock for Q3 2016, up 0.8% quarter-over-quarter.
  • 67 funds opened new Eli Lilly positions in Q3 2016 and 58 closed out, a net change of +9 holders.
  • The largest Eli Lilly buyer in Q3 2016 was Balyasny Asset Management, an estimated $187M added.
  • The largest Eli Lilly seller in Q3 2016 was Viking Global Investors, an estimated $263M sold.

Based on aggregated 13F filings for Q3 2016.